Two African nations became the first countries to approve the new R21/Matrix-M™ malaria vaccine, developed at Oxford University, includes Novavax's world-class adjuvant, and is manufactured by the Serum Institute of India (SII), Pvt. Ltd.
This year, Ghana and Nigeria preempted the World Health Organization (WHO) process and issued their approvals. And about ten other African countries may issue their approvals soon.
New Malaria Vaccine Takes Orders
U.S. NIH Herpes Strategic Plan Seeks Proposals
Over the past decade, the United States has witnessed alarming increases in rates of sexually transmitted infections (STIs), amounting to a public health crisis.
The consequences of the STI epidemic are enormous, wrote the U.S. HHS.
When left untreated, STIs can lead to long-term, irreversible health outcomes such as chronic pelvic pain, infertility, adverse pregnancy outcomes, neonatal death, and congenital abnormalities.
Time to Deliver Zero Malaria by Investing, Innovation, and Implementation
Today marks the 16th World Malaria Day and an appropriate time for everyone to take stock of malaria's devastating impact in the African Region.
It's Time to deliver zero malaria: invest, innovate, and implement, wrote the WHO Regional Director for Africa, Dr. Matshidiso Moeti, on April 25, 2023.
Excerpts from his announcement are included below:
Racial Disparities in Stroke Mortality Increased During Pandemic
Absolute difference in age-adjusted stroke death rate between Black, White adults was 21.7 percent higher during pandemic